Ocugen, Inc. (OCGN)
NASDAQ: OCGN · Real-Time Price · USD
1.240
+0.060 (5.08%)
At close: Nov 28, 2025, 1:00 PM EST
1.230
-0.010 (-0.81%)
After-hours: Nov 28, 2025, 4:59 PM EST
Ocugen Market Cap
Ocugen has a market cap or net worth of $387.28 million as of November 28, 2025. Its market cap has increased by 31.42% in one year.
Market Cap
387.28M
Enterprise Value
387.68M
1-Year Change
31.42%
Ranking
Category
Stock Price
$1.24
Market Cap Chart
Since September 30, 2019, Ocugen's market cap has increased from $32.75M to $387.28M, an increase of 1,082.55%. That is a compound annual growth rate of 49.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 387.28M | 65.14% |
| Dec 31, 2024 | 234.51M | 59.00% |
| Dec 29, 2023 | 147.49M | -48.17% |
| Dec 30, 2022 | 284.55M | -68.60% |
| Dec 31, 2021 | 906.30M | 205.66% |
| Dec 31, 2020 | 296.51M | 983.53% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 290.32B |
| Merck & Co. | 259.69B |
| Novartis AG | 251.09B |
| Abbott Laboratories | 223.51B |